February 20, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - The transition to value-based care for payers is not about enrolling patients. In four separate meetings this year with major affiliated, yet independent payers, we heard differing needs and priorities: 1. More connectivity with practitioners 2. A reduction of the cost and risk […]
February 13, 2017 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - In December 2016, QuintilesIMS reported that US spending on prescription medications will reach upwards of $675 billion by 2021. The pricing pressure on manufacturers is expected to grow along with the demand that specialty therapies, in particular, demonstrate positive outcomes in real-world […]
Audits are one more opportunity to demonstrate the program is working well We can only assume that audits were the focus of so much discussion at this year’s 340B Coalition Winter Conference because the changes that come with the installation of new government officials will inevitably lead to a fresh look at the 340B program. […]
Rumblings of imminent healthcare policy changes were not enough to distract attendees at this year’s J.P. Morgan Healthcare Conference 2017 from their focus on several key themes at this year’s event. Below is a list of our key takeaways from what remains one of the most significant annual healthcare business conferences. The drive to value […]
January 23, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Despite news breaking on the first steps toward the repeal of the Affordable Care Act (ACA) and President-elect Trump’s comments on pharmaceutical manufacturers and pricing, not all was doom and gloom at the J.P. Morgan 35th Annual Healthcare Conference 2017, January 9-12, […]
In honor of National Pharmacist Day on January 12, we would like to take this time to honor the pharmacists that dedicate themselves to serving and helping our patients improve their health outcomes and lives. We greatly appreciate our pharmacists and the fact that they continually act and build upon our vision and belief in […]
January 3, 2017 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the launch of seven 340B clinic partnerships in January 1, 2017: Family Centers Health Care - Greenwich, Connecticut Florida Department of Health, Lee County - Fort Myers, Florida Florida Department of Health, Palm Beach County - […]
January 3, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Every year, the business of healthcare gathers en masse at the annual J.P. Morgan Healthcare Conference. This year’s conference will be held January 9 to January 12 in San Francisco. What will we learn? What will we hear? What will be […]
It will add new tools to the life science toolbox. More patients may begin to receive more medical products than before, due to the fact that the Act includes numerous provisions meant to speed up the approval process for new drugs and devices. It supports evolution of the FDA approval process. “The bill allows for […]
December 14, 2016 - Curant Health Director of Commercial Strategy and Performance, Jake Caines, featured in Managed Healthcare Executive - Congress has approved the 21st Century Cures Act, which aims to speed federal approval of new drugs and devices as well as beef up funding of medical research. It is expected that President Obama will […]
